Olema Pharmaceuticals, Inc. (OLMA)
7.05
-0.20
(-2.76%)
USD |
NASDAQ |
Oct 21, 16:00
7.05
0.00 (0.00%)
After-Hours: 04:46
Olema Pharmaceuticals Net Income (Annual) : -162.45M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -162.45M |
| December 31, 2024 | -129.47M |
| December 31, 2023 | -96.66M |
| December 31, 2022 | -104.79M |
| Date | Value |
|---|---|
| December 31, 2021 | -71.10M |
| December 31, 2020 | -22.12M |
| December 31, 2019 | -4.316M |
| December 31, 2018 | -2.197M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| SELLAS Life Sciences Group, Inc. | -26.86M |
| Puma Biotechnology, Inc. | 31.11M |
| ACADIA Pharmaceuticals, Inc. | 391.00M |
| Alnylam Pharmaceuticals, Inc. | 313.75M |
| Anika Therapeutics, Inc. | -9.979M |